Search hospitals > Maine > Bangor
Eastern Maine Medical Center
Claim this profileBangor, Maine 04401
Global Leader in Cancer
Global Leader in Leukemia
Conducts research for Breast Cancer
Conducts research for Tumors
Conducts research for Lymphoma
356 reported clinical trials
11 medical researchers
Summary
Eastern Maine Medical Center is a medical facility located in Bangor, Maine. This center is recognized for care of Cancer, Leukemia, Breast Cancer, Tumors, Lymphoma and other specialties. Eastern Maine Medical Center is involved with conducting 356 clinical trials across 588 conditions. There are 11 research doctors associated with this hospital, such as Sarah J. Sinclair, Nadine P. SantaCruz, Daniel L. Callaway, and Clifford Singer.Area of expertise
1Cancer
Global LeaderStage IV
Stage I
Stage II
2Leukemia
Global LeaderStage II
Stage IV
Stage III
Top PIs
Sarah J. SinclairLafayette Family Cancer Center-EMMC4 years of reported clinical research
Expert in Cancer
Expert in Breast Cancer
78 reported clinical trials
155 drugs studied
Nadine P. SantaCruzEastern Maine Medical Center7 years of reported clinical research
Expert in Tumors
Expert in Brain Tumor
41 reported clinical trials
89 drugs studied
Daniel L. CallawayEastern Maine Medical Center4 years of reported clinical research
Expert in Tumors
Expert in Brain Tumor
27 reported clinical trials
76 drugs studied
Clifford SingerNorthern Light Acadia Hospital4 years of reported clinical research
Studies Alzheimer's Disease
Studies Alzheimer's Dementia
5 reported clinical trials
8 drugs studied
Clinical Trials running at Eastern Maine Medical Center
Lung Cancer
Non-Small Cell Lung Cancer
Brain Tumor
Osteosarcoma
Germ Cell Tumors
Non-Hodgkin's Lymphoma
Cancer
Neuroblastoma
Langerhans Cell Histiocytosis
Ovarian Tumors
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting2 awards Phase 327 criteria
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Sotorasib
for Non-Small Cell Lung Cancer
This phase II Lung-MAP treatment trial studies the effect of AMG 510 in treating non-squamous non-small cell lung cancer that is stage IV or has come back (recurrent) and has a specific mutation in the KRAS gene, known as KRAS G12C. Mutations in this gene may cause the cancer to grow. AMG 510, a targeted treatment against the KRAS G12C mutation, may help stop the growth of tumor cells.
Recruiting2 awards Phase 219 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Eastern Maine Medical Center?
Eastern Maine Medical Center is a medical facility located in Bangor, Maine. This center is recognized for care of Cancer, Leukemia, Breast Cancer, Tumors, Lymphoma and other specialties. Eastern Maine Medical Center is involved with conducting 356 clinical trials across 588 conditions. There are 11 research doctors associated with this hospital, such as Sarah J. Sinclair, Nadine P. SantaCruz, Daniel L. Callaway, and Clifford Singer.
Where is Eastern Maine Medical Center located?
Eastern Maine Medical Center is located at 489 State St, Bangor, ME 04401, at the intersection of State St and Parkview Ave.
Who should I call to ask about financial aid or insurance network?
For financial assistance and insurance-related inquiries at Eastern Maine Medical Center, contact Patient Account Services at 973-5000. They offer guidance on income guidelines, available financial assistance sources, hospital charges, insurance coverage, and support for individuals without insurance or facing non-covered services.
What insurance does Eastern Maine Medical Center accept?
Eastern Maine Medical Center accepts a wide range of insurance plans, including but not limited to Aetna US Healthcare, Anthem Blue Cross Blue Shield, Cigna Healthcare, Harvard Pilgrim Healthcare (PHCS), MaineCare / Medicaid, Medicare, and Tricare/Champus. It is crucial to verify with your insurance provider about their participation with Eastern Maine Medical Center prior to receiving services.
What awards or recognition has Eastern Maine Medical Center received?
Eastern Maine Medical Center (EMMC) in Bangor, Maine, is a key component of Northern Light Health. It boasts a Clinical Research Center dedicated to supporting research across a broad spectrum of fields such as epidemiological, clinical, behavioral, health services, and outcomes-oriented clinical research. EMMC is celebrated for its collaborative, multidisciplinary research culture and commitment to research excellence.